DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,393,568 | +2.8% | 2,558,563 | 0.0% | 0.13% | +1.6% |
| Q2 2023 | $30,549,242 | +46.6% | 2,558,563 | +64.2% | 0.12% | +27.6% |
| Q1 2023 | $20,837,987 | -37.9% | 1,558,563 | 0.0% | 0.10% | -41.7% |
| Q4 2022 | $33,540,276 | +7.4% | 1,558,563 | 0.0% | 0.17% | +16.7% |
| Q3 2022 | $31,218,000 | -6.1% | 1,558,563 | -16.1% | 0.14% | -5.3% |
| Q2 2022 | $33,248,000 | +189.6% | 1,857,424 | +60.5% | 0.15% | +230.4% |
| Q1 2022 | $11,482,000 | -41.1% | 1,157,424 | 0.0% | 0.05% | -17.9% |
| Q4 2021 | $19,503,000 | -32.2% | 1,157,424 | -4.5% | 0.06% | -29.1% |
| Q3 2021 | $28,746,000 | -5.9% | 1,211,396 | -9.7% | 0.08% | -15.1% |
| Q2 2021 | $30,544,000 | – | 1,341,396 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,548,403 | $54,841,633 | 43.06% |
| PATHWAY CAPITAL MANAGEMENT, LP | 995,686 | $21,427,163 | 38.24% |
| Atlas Venture Life Science Advisors, LLC | 7,568,317 | $162,870,182 | 19.62% |
| RA Capital Management | 7,040,622 | $151,514,185 | 3.07% |
| COMMODORE CAPITAL LP | 739,661 | $15,918 | 2.40% |
| GREAT POINT PARTNERS LLC | 544,451 | $11,716,586 | 2.30% |
| Nicholas Investment Partners, LP | 786,554 | $16,926,642 | 1.48% |
| Boxer Capital, LLC | 1,189,943 | $25,607,573 | 1.35% |
| Parkman Healthcare Partners LLC | 224,483 | $4,830,874 | 1.29% |
| Cheyne Capital Management (UK) LLP | 27,223 | $585,839 | 1.02% |